Evidence map›Paper›PMID 39009921›Full record

ArticleEndocrine2024

A novel nomogram for predicting the risk of persistent hyperparathyroidism after kidney transplantation.

Changyu Ma, Congrong Shen, Haotian Tan, Ziyin Chen, Zhenshan Ding, Ying Zhao, Xiaofeng Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Changyu Ma *Department of Urology, China-Japan Friendship Hospital, Beijing, China.
Congrong Shen *Department of Urology, China-Japan Friendship Hospital, Beijing, China.
Haotian TanDepartment of Urology, China-Japan Friendship Hospital, Beijing, China.
Ziyin ChenDepartment of Urology, China-Japan Friendship Hospital, Beijing, China.
Zhenshan DingDepartment of Urology, China-Japan Friendship Hospital, Beijing, China.
Ying ZhaoDepartment of Urology, China-Japan Friendship Hospital, Beijing, China.
Xiaofeng ZhouDepartment of Urology, China-Japan Friendship Hospital, Beijing, China. cjfhurology@163.com.

Funding

Beijing Demonstration Research Ward Construction Project 2022-YJXBF-04-05
6 · The paper itself

Abstract

purposePersistent hyperparathyroidism (PTHPT) in kidney transplant recipients is associated with bone loss, graft dysfunction and cardiovascular mortality. There is no clear consensus on the management of PTHPT. Accurate risk prediction of the disease is needed to support individualized treatment decisions. We aim to develop a useful predictive model to provide early intervention for hyperparathyroidism in these patients.

methodsWe retrospectively analyzed 263 kidney transplantations in the urology department of China-Japan Friendship Hospital from January 2018 to December 2022. The overall cohort was randomly assigned 70% of the patients to the training cohort and 30% to the validation cohort. Univariate and multivariate logistic regression analyses were used to identify independent risk factors for PTHPT and to construct the predictive model. This model was assessed regarding discrimination, consistency, and clinical benefit.

resultsThe occurrence of PTHPT was 25.9% (68 out of 263 patients) in this study. Dialysis duration, postoperative 3-month intact parathyroid hormone (iPTH), 3-month corrected calcium (cCa), and 3-month phosphorus (P) are independent risk factors for the development of PTHPT. The nomogram showed good discrimination with the area under the curve (AUC) value of 0.926 in the training cohort and 0.903 in the validation cohort. The calibration curve and decision curve also showed that the model was well-evaluated.

conclusionWe developed a validated nomogram model to predict PTHPT after kidney transplantation. This can help the clinic prevent and control PTHPT early and improve patients' prognosis.

Indexed as

Kidney TransplantationNomogramsAdultAgedCalciumFemaleHumansHyperparathyroidismMaleMiddle AgedParathyroid HormonePostoperative ComplicationsPrognosisRetrospective StudiesRisk AssessmentRisk FactorsCalciumParathyroid HormoneKidney transplantationNomogramPersistent hyperparathyroidismPredictive model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.